A Baltimore biotechnology company is raising up to $40.5 million and working to develop pharmaceutical technology born out of Johns Hopkins University. Dracen Pharmaceuticals Inc. is working to develop technologies conceptualized by Barbara Slusher, a professor of neurology, and Dr. Jonathan Powell, a professor of oncology at Johns Hopkins School of Medicine. Dracen has entered an exclusive agreement with Hopkins and the Institute of Organic Chemistry and Biochemistry in Prague to license the jointly-owned…
from https://www.bizjournals.com/baltimore/news/2018/01/29/johns-hopkins-born-pharma-company-raising-40-5.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/170272206742
No comments:
Post a Comment